FindTrial
Sign In

Retrospective descriptive analysis of 9 patients with MSI-H lung cancer

Retrospective descriptive analysis of 9 patients with MSI-H lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049504
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-07-22
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Case series:No

Sponsors

Daping Hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
58 Years to 78 Years

Inclusion criteria

Inclusion criteria: 1. To collect patients with non-small cell lung cancer pathologically diagnosed from January 2018 to January 2021, including locally advanced, metastatic, postoperative recurrence or poor response after chemotherapy; 2. Genetic testing: MSI-H.

Exclusion criteria

Exclusion criteria: 1. Co-infection; 2. Treatment information is unknown; 3. Poor patient compliance; 4. Minor patients, pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Therapeutic Evaluation;—

Countries

China

Contacts

Public ContactLi Li

Daping Hospital, Army Medical University

lili10119@126.com+86 23 68757780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026